Chembio Diagnostic Systems, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 04/17/12 -- is pleased to announce that (OTCQB: CEMI) (PINKSHEETS: CEMI) will be presenting at our 9th Annual Small Cap Equity Conference May 1, 2012. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to , contact at 212-779-2971 or visit .
. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.
Chembio Diagnostic Systems, Inc. (OTCQB: CEMI) (PINKSHEETS: CEMI) develops, manufactures, licenses and markets point-of-care (POC) diagnostic tests and technology for the detection of infectious diseases. Chembio's patented Dual Path Platform (DPP®) POC technology enables development of POC assays that provide unique features and capabilities such as multiplexing and improved control of challenging sample types, such as oral fluid. An oral fluid HIV test is anticipated to be submitted to and reviewed by the FDA in 2012. Several other tests have also been developed on DPP® and revenues in this product line are expected to grow significantly in 2012. Chembio has been profitable since 2009 and anticipates continued revenue growth and profitability in 2012.
Contact:
Taglich Brothers
Karen Payne
Symposia Events
212-779-2971
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.04.2012 - 16:30 Uhr
Sprache: Deutsch
News-ID 136024
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Chembio Diagnostic Systems, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Chembio Diagnostic Systems, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
